Publications

Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum β-lactamase (ESBL) in a hospital with high prevalence of this infection. by Marra AR, Pereira CA, Castelo A, do Carmo Filho JR, Cal RG, Sader HS and Wey SB published in Int. J. Infect. Dis. 2006; 10 (1): 56-60

Contemporary antimicrobial activity of triple antibiotic ointment: A multiphased study of recent clinical isolates in the United States and Australia. by Jones RN, Li Q., Kohut B, Biedenbach DJ, Bell J, Turnidge JD published in Diagn. Microbiol. Infect. Dis. 2006; 54 (1): 63-71

Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables. by Hammel JP, Bhavnani SM, Jones RN, Forrest A, Ambrose PG published in Antimicrob. Agents Chemother. 2006; 50 (1): 62-67

Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: Report from the Sentry Antimicrobial Surveillance Program (1997-2004). by Biedenbach DJ, Toleman M, Walsh TR, and Jones RN published in Diagn. Microbiol. Infect. Dis. 2006; 54 (1): 13-21

Oxazolidinone susceptibility patterns in 2004: Report from the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) program assessing isolates from 16 nations. by Jones, R.N., Ross, J.E., Fritsche, T.R., and Sader, H.S. published in J. Antimicrob. Chemother. 2006; 57 (2): 279-287

Carbapenem susceptibility discords among Acinetobacter isolates. by Jones RN, Sader HS, Fritsche TR and Rhomberg PR published in Clin, Infect. Dist. 2006; 42 (1): 158

An In Vitro Evaluation of Combination Cefepime and Sulbactam Effects on Methicillin-Resistant Staphylococcus aureus (MRSA), Lead author: Leuthner, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Susceptibility Breakpoint Decision Support: Use of Monte Carlo Simulation and Bootstrapping to Establish Minimum Bacterial Isolate Sample Size, Lead author: Ambrose PG, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

In Vivo Pharmacodynamic Activity of Gatifloxacin (GATI), Levofloxacin (LEVO), and Moxifloxacin (MOXI) against Staphylococcus aureus with Reduced Susceptibility to Fluoroquinolones (FQs), Lead author: Craig WA, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Impact of Cefepime and Sulbactam Combination on Resistance Development on Clinical Strains of Multi-Drug Resistant Acinetobacter Spp. (MDR-A), Lead author: Leuthner, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

First Spontaneous Occurrence of High-Level Resistance (R) to the Peptide Deformylase (PDF) Inhibitor (PDI) LBM415 in Staphylococcus aureus (SA) Detected in a Clinical Setting, Lead author: Fritsche TR, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Pseudomonas aeruginosa Oxacillinase Gene, bla_oxa-45, Lies Adjacent to a New CR Element, CR5, which Provides Promoter Sequences for Expression, Lead author: Walsh T, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Inter-Species Dissemination of an Integron Carrying bla_VIM-1 between Pseudomonas aeruginosa and Enterobacter cloacae, Lead author: Castanheira M, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Sequencing Analysis of the Texan 24kb Plasmid Mobilizing the Metallo-&#223-Lactamase Gene, bla_Vim-7, from Pseudomonas aeruginosa, Lead author: Li, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Evaluation of Occurrence and Characterization of Carbapenemases among Enterobacteriaceae Isolated by the SENTRY Antimicrobial Surveillance Program Worldwide (2000-2004), Lead author: Sader HS, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

A Novel Mobile CR Element, CR6, is Associated with Carriage of DHFR Genes in Cotrimoxazole Susceptible Stenotrophomonas maltophilia Isolates, Lead author: Walsh T, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Emergence and Epidemiology of Fluoroquinolone-Resistant S. pneumoniae Isolates from Italy: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004), Lead author: Deshpande LM, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Eight Year Summary of Community-Acquired S. pneumoniae Infections by the SENTRY Antimicrobial Surveillance Program (1997-2004): More Good News Than Bad!, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Characterization of Enterococcal Isolates with Linezolid MIC at 4 ug/ml Collected as Part of the ZAAPS Oxazolidinone Surveillance Program (2002-2004), Lead author: Sader HS, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Oxazolidinone Susceptibility Patterns in 2004: Report from the Worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program, Lead author: Ross JE, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Frequency of Occurrence and Antimicrobial Susceptibility (S) of Bacterial Isolates Causing Bloodstream Infections Worldwide: Report from 8 Years of the SENTRY Antimicrobial Surveillance Program (1997-2004), Lead author: Sader HS, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Dissemination of bla_KPC-2/3 among Clinical Strains of Enterobacteriaceae Isolated in New York City and other Medical Centers: Report from the MYSTIC Program (2005), Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Dissemination of bla_vim among Clonally Unrelated Clinical Strains Isolated in an USA Medical Center, Lead author: Sader HS, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Emergence of Imp and Vim Metallo-Beta-Lactamase Producing P. aeruginosa Strains in Mexico: Report from the Sentry Antimicrobial Surveillance Program, Lead author: Sader HS, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Evaluation of Daptomycin (DAP), Telavancin (TLV), Teicoplanin (TEI), and Vancomycin (VAN) Activity in the Presence of Albumin or Serum, Lead author: Tsuji, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

In Vitro Susceptibility Testing Guidelines for Ceftobiprole (BAL9141) Using CLSI Disk Diffusion and Broth Microdilution MIC Methods, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Accuracy for Antibacterial and Antifungal Susceptibility Tests: Report from the College of American Pathologists (CAP) Microbiology Proficiency Survey Program for 2004 – 2005, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Susceptibility Testing Accuracy of an Enterobacteriaceae Population Enriched for Ctx-M-Type ESBL-Producing Isolates (China): Intermethod Analysis for Nine Important Parenteral ß-Lactams, Lead author: Pottumarthy S, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Importance of Medium, Calcium Concentration, Time of Incubation, and Inoculum for Testing Polymyxin B (PB) against Acinetobacter spp. (ASP) and Pseudomonas aeruginosa (PSA), Lead author: Mendes RE, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Validation of Etest Colistin (CO) and Polymyxin B (PO) against the CLSI Reference Methods using 413 Strains with a Wide Susceptibility Range, Lead author: Bolmstrom A, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Wild-Type MIC Distributions for Campylobacter spp. Tested against Nine Antimicrobials using Recently Approved CLSI Broth Microdilution (BMD) Methods (2005), Lead author: Fritsche TR, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Faropenem Activity Tested against Neisseria gonorrhoeae Including Contemporary Antimicrobial Resistance Phenotypes, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Tigecycline (GAR-936) Activity against 850 Bloodstream Infection (BSI) Isolates of Viridans Group Streptococci, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Antimicrobial Spectrum and Potency of Cefepime Combined with Sulbactam when Tested with 4 Candidate Ratio or Fixed Concentration Formulations, Lead author: Sader HS, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Targeting Aerobic and Facultative Gram-negative Bacilli, Gram-positive Anaerobes and Select Agent Surrogate Strains, Lead author: Savage, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of a Novel Cationic Steroid Antimicrobial (CSA-13) Against Staphylococcus aureus and Bacterial Species Associated with Infections in Cystic Fibrosis Patients, Lead author: Savage, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Antimicrobial Activity of BP-102, A Novel Carbacephem, Tested Against H. influenzae, M. catarrhalis and Various Gram-Positive Cocci, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of VIC-105555 (VIC), a Novel Lincosamide, Tested Against Gram-Positive Bacteria and Anaerobes, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Comparative Antimicrobial Activity and Spectrum of Retapamulin (RE) Against Drug-Resistant Organisms, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Quality Control Guidelines for Testing Retapamulin by CLSI Broth Microdilution and Disk Diffusion Methods, Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Assessment of Pathogen Frequency and Resistance (R) Patterns Among Pediatric Patients (PP): Report from the SENTRY Antimicrobial Surveillance Program (2004) on Three Continents, Lead author: Fedler K, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Evaluation of Clinical Outcome among Patients with ESBL-Producing Enterobacteriaceae (ETB) Treated with Cephalosporin (CEPH) Monotherapy, Lead author: Craig WA, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Geographic Antimicrobial Resistance Variability among Bacterial Pathogens Causing Nosocomial Pneumonia in North America (NA): An Eight-Year Analysis from the SENTRY Antimicrobial Surveillance Program, 1997-2004, Lead author: Biedenbach DJ, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Activity of Gemifloxacin Tested against Historical and Contemporary Isolates of Neisseria gonorrhoeae (NG) Including Fluoroquinolone-Resistant Strains (QRNG), Lead author: Jones RN, presented at 45th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), December 16 – 19, 2005, Washington, DC

Re-Evaluation of the Bactericidal Activities and the Correlation between Disk Diffusion and MIC Methods for Testing Daptomycin and Vancomycin against S. aureus with Decreased Susceptibility (S) to Gylcopeptides, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Antimicrobial Activities of Cefepime and Piperacillin/Tazobactam against E. coli and Klebsiella spp. with ESBL-Phenotype Collected Worldwide, Lead author: Sader HS, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Potential Role for Triple Antibiotic Ointment (TAO) Against Mupirocin-Resistant Staphylococci: A USA and Australian Clinical Isolate Sample, Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Daptomycin Resistance and Vancomycin Intermediate S. aureus in a Patient with Prolonged Antibiotic Therapy, Lead author: Mariani P, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Global Assessment of the Polymyxin B Activity Tested against 55,151 Clinical Strains of Gram-Negative Bacilli: Report from the SENTRY Antimicrobial Surveillance Program (2001-2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California

Spectrum and Potency of Dalbavancin Tested against 3,322 Gram-Positive Cocci Isolated in the USA Surveillance Program (2004), Lead author: Jones RN, presented at 43rd annual Infectious Diseases Society of America (IDSA), October 6 – 9, 2005, San Francisco, California